Trials / Completed
CompletedNCT06526026
An Innovative Mental Health Virtual Ward: Evaluation of Patient-Centered Outcomes
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 66 (actual)
- Sponsor
- University of Manitoba · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this study is to evaluate if admission to the Mental Health Virtual Ward (MH vWard) for mental health crisis stabilization is having a meaningful positive impact on patient reported outcomes and healthcare utilization. The objectives of this study are: 1. Prospectively measure demographic, recovery, service delivery, and systems use outcomes in a cohort of MH vWard admissions. 2. establish this cohort for use in future research. As part of the intervention, participants will receive care in the MH vWard for an average of 5 days following a visit to an emergency department or crisis centre for a mental health crisis. While admitted to the MH vWard, participants will: 1. Engage in individual therapy and care planning with a clinician or psychiatry team. 2. Have engagement with formal (community providers) and informal supports (family, friends) for collateral and collaboration. 3. Receive medication reconciliation and management. 4. Participate in group programming. 5. Receive referrals for follow-up services. 6. Have access to after hours support. 7. Have access to the Telus Home Health Monitoring (HHM) App, which is custom designed to complement the services provided by the program.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Virtual crisis stabilization support with a multi-disciplinary team | Daily 1:1 sessions with multidisciplinary team via a range of virtual modalities (videoconferencing, phone, text, email), group programming, self-management resources, remote home monitoring app, referrals and linkages to community programs. |
Timeline
- Start date
- 2024-07-22
- Primary completion
- 2025-07-29
- Completion
- 2025-07-29
- First posted
- 2024-07-29
- Last updated
- 2025-08-06
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT06526026. Inclusion in this directory is not an endorsement.